biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by KayakerBCon Sep 16, 2016 4:32pm

109 Views

Post# 25246753

RE:RE:RE:RE:RE:RE:Regardless - the idiot

Narmac, as I said to you in one of those posts when you were bashing BTI EXACTLY at the bottom....

"I'm going to remind you of this missed opportunity to buy BTI in the 70¢ to 75¢ range, and how you got it exactly wrong."

Who's sorry now.

Anyhow, it's nice to see some of the usual suspects finally "getting it", especially after all the years some of us put in countering the endless uninformed opinions and misinformation.

Of course, the entertaining part (in the not-too-distant future) will be watching some of those same folks post their revisionist history and crow about how they had it figured out all along.

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute